The data presented herein represent the first gene expression profile in Mexican HNSCC patients comparing HPV+/p16+ versus HPV−/p16− and contribute to the potential identification of prognostic biomarkers and therapeutic targets in HNSCC. This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.